EGFR and breast cancer: We are comfortably convinced that CD32-CR–mediated cytotoxicity is an independent function because either human serum or purified IgGs failed to protect sensitive EGFR-positive BC cells from CD32-CR T cells, but rather their killing was enhanced in the presence of cetuximab.